Clinical trials of β-blockers in heart failure: A class review

American Journal of Medicine

Volumn 110, Issue 5 SUPPL. 1, 2001, Pages 7-10

  Yancy, Clyde W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL;

CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG PREFERENCE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HORMONE RESPONSE; HUMAN; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

EID: 0035794938     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(01)00666-0     Document Type: Review

References (14)

1. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
4. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
5. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
6. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
7. A randomized trial of beta blockade in heart failure
8. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
9. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
10. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
11. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)
12. BEST (Beta-blockers Evaluation Survival Trial)
13. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: Pharmacological approaches
14. COPERNICUS (Carvedilol Prospective Randomized Cumulative Survival Trial)